China National Medicines Corp Ltd
SSE:600511
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
CN |
|
J
|
Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd
SSE:688076
|
CN |
|
Innovatec SpA
MIL:INC
|
IT |
Wall St Price Targets
Price Targets Summary
China National Medicines Corp Ltd
According to Wall Street analysts, the average 1-year price target for China National Medicines Corp Ltd is 37.16 CNY with a low forecast of 35.21 CNY and a high forecast of 39.9 CNY.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is China National Medicines Corp Ltd's stock price target?
Price Target
37.16
CNY
According to Wall Street analysts, the average 1-year price target for China National Medicines Corp Ltd is 37.16 CNY with a low forecast of 35.21 CNY and a high forecast of 39.9 CNY.
What is the Revenue forecast for China National Medicines Corp Ltd?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 3 years is 4%.
What is the Operating Income forecast for China National Medicines Corp Ltd?
Projected CAGR
81%
Over the last 13 years, the compound annual growth rate for Operating Income has been 18%. The projected CAGR for the next 1 year is 81%.
What is the Pre-Tax Income forecast for China National Medicines Corp Ltd?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 15%. The projected CAGR for the next 3 years is 3%.
What is the Net Income forecast for China National Medicines Corp Ltd?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Net Income has been 15%. The projected CAGR for the next 3 years is 3%.